JNJ

167.69

-0.36%↓

NVS

116.94

-0.3%↓

ABT

128.18

+0.74%↑

MDT

92.11

-0.35%↓

ELV.US

287.61

-2.37%↓

JNJ

167.69

-0.36%↓

NVS

116.94

-0.3%↓

ABT

128.18

+0.74%↑

MDT

92.11

-0.35%↓

ELV.US

287.61

-2.37%↓

JNJ

167.69

-0.36%↓

NVS

116.94

-0.3%↓

ABT

128.18

+0.74%↑

MDT

92.11

-0.35%↓

ELV.US

287.61

-2.37%↓

JNJ

167.69

-0.36%↓

NVS

116.94

-0.3%↓

ABT

128.18

+0.74%↑

MDT

92.11

-0.35%↓

ELV.US

287.61

-2.37%↓

JNJ

167.69

-0.36%↓

NVS

116.94

-0.3%↓

ABT

128.18

+0.74%↑

MDT

92.11

-0.35%↓

ELV.US

287.61

-2.37%↓

Search

Pulse Biosciences Inc

Deschisă

SectorSănătate

14.9 1.15

Rezumat

Modificarea prețului

24h

Curent

Minim

14.56

Maxim

14.98

Indicatori cheie

By Trading Economics

Venit

2.6M

-17M

Vânzări

832K

832K

Marjă de profit

-2,018.63

Angajați

75

EBITDA

1.9M

-18M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+44.64% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-184M

1B

Deschiderea anterioară

13.75

Închiderea anterioară

14.9

Sentimentul știrilor

By Acuity

50%

50%

157 / 375 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Pulse Biosciences Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

29 iul. 2025, 23:57 UTC

Achiziții, Fuziuni, Preluări

EQT: To Spend Y407.82B for Tender Offer

29 iul. 2025, 23:56 UTC

Achiziții, Fuziuni, Preluări

EQT: Tender Offer Price Is Y5,700 a Share

29 iul. 2025, 23:54 UTC

Achiziții, Fuziuni, Preluări

EQT To Start Tender Offer for Fujitec

29 iul. 2025, 23:50 UTC

Market Talk

Nikkei May Fall Amid Uncertainty Over Earnings, Domestic Politics -- Market Talk

29 iul. 2025, 23:36 UTC

Market Talk

Gold Steady Ahead of FOMC Decision -- Market Talk

29 iul. 2025, 22:57 UTC

Market Talk

Perseus May Step Up Capital Management at FY 2025 Result -- Market Talk

29 iul. 2025, 22:50 UTC

Market Talk

Mondelez Warns of Price Increases in North America -- Market Talk

29 iul. 2025, 22:44 UTC

Achiziții, Fuziuni, Preluări

St Barbara: Potential Divestment of Nova Scotia Ops to be Weighed in 1Q FY26

29 iul. 2025, 22:41 UTC

Achiziții, Fuziuni, Preluări

St Barbara FY25 All-in Sustaining Cost A$4,582/Oz

29 iul. 2025, 22:41 UTC

Achiziții, Fuziuni, Preluări

St Barbara 4Q All-in Sustaining Cost A$4,613/Oz

29 iul. 2025, 22:35 UTC

Câștiguri

IGO Maintains Nova Life of Mine Production Guidance

29 iul. 2025, 22:35 UTC

Câștiguri

IGO Expects FY 2026 Greenbushes Output of 1.50 Million-1.65 Million Tons

29 iul. 2025, 22:35 UTC

Câștiguri

IGO Expects FY 2026 Greenbushes Cash Costs of A$310-A$360/Ton

29 iul. 2025, 22:34 UTC

Câștiguri

IGO Expects Train 1 of Kwinana Refinery to Be Fully Impaired

29 iul. 2025, 22:34 UTC

Câștiguri

IGO Expects to Impair Kwinana Refinery Assets by A$70 Million-A$90 Million

29 iul. 2025, 22:34 UTC

Market Talk
Câștiguri

Mondelez Snack Demand Holding Up Better in Europe Than U.S. -- Market Talk

29 iul. 2025, 22:33 UTC

Câștiguri

IGO Had A$279.7 Million of Cash at End-June

29 iul. 2025, 22:33 UTC

Câștiguri

IGO 4Q Underlying Free Cash A$2.4 Million

29 iul. 2025, 22:33 UTC

Câștiguri

IGO FY Sales Revenue A$512.5 Million

29 iul. 2025, 22:33 UTC

Câștiguri

IGO 4Q Sales Revenue A$126.9 Million, Up 15% on 3Q

29 iul. 2025, 22:32 UTC

Câștiguri

IGO FY Nickel Production 17,173 Tons

29 iul. 2025, 22:32 UTC

Câștiguri

IGO 4Q Nickel Production 5,107 Tons, Up 22% on 3Q

29 iul. 2025, 22:32 UTC

Câștiguri

IGO 4Q Lithium Hydroxide Production 2,126 Tons, Up 36% on 3Q

29 iul. 2025, 22:31 UTC

Market Talk
Câștiguri

Global Equities Roundup: Market Talk

29 iul. 2025, 22:31 UTC

Market Talk
Câștiguri

Mondelez Sees Consumers Trading Down, Buying in Bulk -- Market Talk

29 iul. 2025, 22:31 UTC

Câștiguri

IGO 4Q Spodumene Cash Cost A$366/Ton, Up 7% on 3Q

29 iul. 2025, 22:31 UTC

Câștiguri

IGO FY Spodumene Production 1.48 Million Tons

29 iul. 2025, 22:30 UTC

Câștiguri

IGO 4Q Spodumene Production 340,000 Tons, Flat on 3Q

29 iul. 2025, 22:30 UTC

Câștiguri

IGO 4Q Underlying Ebitda A$62 Million

29 iul. 2025, 22:22 UTC

Câștiguri

Starbucks Abandons Mobile Order, Pickup-Only Stores -- WSJ

Comparație

Modificare preț

Pulse Biosciences Inc Așteptări

Obiectiv de preț

By TipRanks

44.64% sus

Prognoză pe 12 luni

Medie 22 USD  44.64%

Maxim 22 USD

Minim 22 USD

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPulse Biosciences Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

1 ratings

1

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

16.59 / 17.17Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

157 / 375 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.